Nitrous Oxide

Nitrous oxide, commonly known as laughing gas, is an inhaled minimal sedation agent delivered as a mixture of nitrous oxide and oxygen through a nasal mask during dental procedures. The gas produces anxiolytic, analgesic, and mild sedative effects within two to three minutes of inhalation, allowing the patient to remain conscious and responsive while experiencing reduced anxiety and an elevated pain threshold. The concentration of nitrous oxide is titrated by the clinician, typically ranging from 30 to 50 percent, and can be adjusted throughout the procedure based on the patient's response. Upon completion of the procedure, the patient breathes 100 percent oxygen for several minutes to flush residual nitrous oxide from the lungs, and the effects dissipate rapidly, usually within five minutes.

Nitrous oxide sedation is widely used in general dentistry, pediatric dentistry, and oral surgery for patients with mild to moderate dental anxiety, strong gag reflexes, or difficulty tolerating lengthy procedures. It is one of the safest sedation modalities available because the patient maintains protective airway reflexes and can communicate throughout the appointment. Unlike oral sedation or intravenous sedation, nitrous oxide does not require an escort to drive the patient home, which reduces appointment barriers for working adults. Dental practices that offer nitrous oxide must comply with state regulations regarding equipment standards, gas scavenging systems to protect staff from chronic occupational exposure, and documentation requirements for sedation administration. Some states require additional permits or training beyond the standard dental license to administer nitrous oxide.

Nitrous oxide analgesia is reported under CDT code D9230. While many dental plans cover this code, others classify it as an elective service and exclude it from reimbursement, leaving the cost as an out-of-pocket patient expense. Practices should verify coverage on a per-patient basis and communicate the expected cost before administering the sedation. For practices that see a high volume of anxious or pediatric patients, nitrous oxide represents a meaningful ancillary revenue stream that also improves patient compliance and reduces cancellation rates. The billing team should document the start and end times of nitrous oxide administration, the concentrations used, and the clinical indication for sedation in the patient record to support the claim and satisfy any audit documentation requirements.